The Center
Multiple Sclerosis Center Dresden
Patient Information
Contact MSC
Physicians & Nurses
Study Team
Neuropsychology
Mobility Center
The Mobility Center
Walking Assessment
Jump Assessment
DIERS
EMIQ
Projects
Neuroimmunological Laboratory
The NIL
Neurofilament light chain
Autonomic & Neuroendocrinological Functional Laboratory
The ANF
ANF Assessment
MS Living Lab
Management & Science
Team Management & Science
Projects
eHealth & Analytics
MSDS 3D
MSDS Clinic & Practice
MS-HRS
MTRS
Multiple Sclerosis Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
MS Tag 2025
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Spenden
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Neurovision
Digital calender 2026
Sherlock-MS-Blog
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
English
Deutsch
English
Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosis
ANF
Jahr
Publikationsjahr
2024
Autoren
Autorenliste der Publikation
Constantinescu V, Haase R, Akgün K, Ziemssen T.
Verlag
Publisher-Information
Front. Pharmacol. 2024. 15:1431380.
Link
Zur Publikation (externer Server)
https://doi.org/10.3389/fphar.2024.1431380
Tags
Forschungsthemen
Multiple Sklerose
MS Behandlung
Autonomes Nervensystem & Neuroendokrinologie
Herzratenvariabilität
Baroreflexsensitivität
MSZ
Treatments
ANF
2024
BRS
HRV
Embodied conversational agents for collecting patient-reported data: effective for some, challenging for others – results of a cross-sectional study in multiple sclerosis care
MASC
Jahr
2026
Kappa free light chains in cerebrospinal fluid to detect inflammation - results from a multicentric prospective real-world study
NIL
Jahr
2026
AI-enabled Living Labs: Accelerating innovation in multiple sclerosis care and research
MASC
Jahr
2026
MS360°: a conceptual digital-first, data-driven hybrid care framework for personalised multiple sclerosis management
MASC
Jahr
2026
Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews
Multiple Sclerosis
Jahr
2026
